• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铁死亡中 mA 修饰的调控及其在放射增敏中的潜在意义。

Regulation of mA modification on ferroptosis and its potential significance in radiosensitization.

作者信息

Chen Xun, Zhang Lejia, He Yi, Huang Siyuan, Chen Shangwu, Zhao Wei, Yu Dongsheng

机构信息

Hospital of Stomatology, Guanghua School of Stomatology, Guangdong Provincial Key Laboratory of Stomatology, Sun Yat-sen University, Guangzhou, 510055, People's Republic of China.

Guangdong Key Laboratory of Pharmaceutical Functional Genes, State Key Laboratory for Biocontrol, Department of Biochemistry, School of Life Sciences, Sun Yat-sen University, Guangzhou, 510275, People's Republic of China.

出版信息

Cell Death Discov. 2023 Sep 15;9(1):343. doi: 10.1038/s41420-023-01645-1.

DOI:10.1038/s41420-023-01645-1
PMID:37714846
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10504338/
Abstract

Radiotherapy is often used to treat various types of cancers, but radioresistance greatly limits the clinical efficiency. Recent studies have shown that radiotherapy can lead to ferroptotic cancer cell deaths. Ferroptosis is a new type of programmed cell death caused by excessive lipid peroxidation. The induction of ferroptosis provides a potential therapeutic strategy for radioresistance. As the most common post-transcriptional modification of mRNA, mA methylation is widely involved in the regulation of various physiopathological processes by regulating RNA function. Dynamic mA modification controlled by mA regulatory factors also affects the susceptibility of cells to ferroptosis, thereby determining the radiosensitivity of tumor cells to radiotherapy. In this review, we summarize the mechanism and significance of radiotherapy induced ferroptosis, analyze the regulatory characteristics of mA modification on ferroptosis, and discuss the possibility of radiosensitization by enhancing mA-mediated ferroptosis. Clarifying the regulation of mA modification on ferroptosis and its significance in the response of tumor cells to radiotherapy will help us identify novel targets to improve the efficacy of radiotherapy and reduce or overcome radioresistance.

摘要

放射疗法常用于治疗各种类型的癌症,但放射抗性极大地限制了临床疗效。最近的研究表明,放射疗法可导致癌细胞发生铁死亡。铁死亡是一种由过度脂质过氧化引起的新型程序性细胞死亡。诱导铁死亡为放射抗性提供了一种潜在的治疗策略。作为mRNA最常见的转录后修饰,m⁶A甲基化通过调节RNA功能广泛参与各种生理病理过程的调控。由m⁶A调控因子控制的动态m⁶A修饰也会影响细胞对铁死亡的敏感性,从而决定肿瘤细胞对放射疗法的放射敏感性。在本综述中,我们总结了放射疗法诱导铁死亡的机制和意义,分析了m⁶A修饰对铁死亡的调控特征,并讨论了通过增强m⁶A介导的铁死亡实现放射增敏的可能性。阐明m⁶A修饰对铁死亡的调控及其在肿瘤细胞对放射疗法反应中的意义,将有助于我们识别新的靶点,以提高放射疗法的疗效并降低或克服放射抗性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7703/10504338/6702c9b68867/41420_2023_1645_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7703/10504338/eb68c4509808/41420_2023_1645_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7703/10504338/07e212182037/41420_2023_1645_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7703/10504338/89e86791f08f/41420_2023_1645_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7703/10504338/6702c9b68867/41420_2023_1645_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7703/10504338/eb68c4509808/41420_2023_1645_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7703/10504338/07e212182037/41420_2023_1645_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7703/10504338/89e86791f08f/41420_2023_1645_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7703/10504338/6702c9b68867/41420_2023_1645_Fig4_HTML.jpg

相似文献

1
Regulation of mA modification on ferroptosis and its potential significance in radiosensitization.铁死亡中 mA 修饰的调控及其在放射增敏中的潜在意义。
Cell Death Discov. 2023 Sep 15;9(1):343. doi: 10.1038/s41420-023-01645-1.
2
Coordination-driven FBXW7 DNAzyme-Fe nanoassembly enables a binary switch of breast cancer cell cycle checkpoint responses for enhanced ferroptosis-radiotherapy.协调驱动的 FBXW7 DNAzyme-Fe 纳米组装体实现了乳腺癌细胞周期检查点反应的二元开关,增强了铁死亡-放疗。
Acta Biomater. 2023 Oct 1;169:434-450. doi: 10.1016/j.actbio.2023.07.042. Epub 2023 Jul 27.
3
The mA modification of ACSL4 mRNA sensitized esophageal squamous cell carcinoma to irradiation via accelerating ferroptosis.m A 修饰 ACSL4 mRNA 通过加速铁死亡使食管鳞癌细胞对辐射敏感。
Cell Biol Int. 2024 Dec;48(12):1877-1890. doi: 10.1002/cbin.12245. Epub 2024 Sep 16.
4
Targeting GSTP1-dependent ferroptosis in lung cancer radiotherapy: Existing evidence and future directions.靶向肺癌放疗中GSTP1依赖的铁死亡:现有证据与未来方向。
Front Mol Biosci. 2022 Dec 16;9:1102158. doi: 10.3389/fmolb.2022.1102158. eCollection 2022.
5
COMMD10 inhibits HIF1α/CP loop to enhance ferroptosis and radiosensitivity by disrupting Cu-Fe balance in hepatocellular carcinoma.COMMD10 通过破坏肝癌中的铜铁平衡抑制 HIF1α/CP 循环来增强铁死亡和放射敏感性。
J Hepatol. 2022 May;76(5):1138-1150. doi: 10.1016/j.jhep.2022.01.009. Epub 2022 Jan 29.
6
SOCS2-enhanced ubiquitination of SLC7A11 promotes ferroptosis and radiosensitization in hepatocellular carcinoma.SOCS2 增强的 SLC7A11 泛素化促进肝癌中的铁死亡和放射增敏作用。
Cell Death Differ. 2023 Jan;30(1):137-151. doi: 10.1038/s41418-022-01051-7. Epub 2022 Aug 22.
7
Ferroptosis, radiotherapy, and combination therapeutic strategies.铁死亡、放疗及联合治疗策略。
Protein Cell. 2021 Nov;12(11):836-857. doi: 10.1007/s13238-021-00841-y. Epub 2021 Apr 23.
8
Ferroptosis in lung cancer: a novel pathway regulating cell death and a promising target for drug therapy.肺癌中的铁死亡:一种调节细胞死亡的新途径及有前景的药物治疗靶点。
Cell Death Discov. 2023 Apr 1;9(1):110. doi: 10.1038/s41420-023-01407-z.
9
Targeting Ferroptosis by Ubiquitin System Enzymes: A Potential Therapeutic Strategy in Cancer.靶向泛素系统酶的铁死亡:癌症治疗的潜在策略。
Int J Biol Sci. 2022 Aug 29;18(14):5475-5488. doi: 10.7150/ijbs.73790. eCollection 2022.
10
The role of ferroptosis in lung cancer.铁死亡在肺癌中的作用。
Biomark Res. 2021 Nov 6;9(1):82. doi: 10.1186/s40364-021-00338-0.

引用本文的文献

1
Emerging dual role of ferroptosis in lung cancer (Review).铁死亡在肺癌中的新兴双重作用(综述)
Oncol Rep. 2025 Nov;54(5). doi: 10.3892/or.2025.8974. Epub 2025 Aug 24.
2
The role of histone methyltransferases in therapeutic resistance of NSCLC.组蛋白甲基转移酶在非小细胞肺癌治疗耐药中的作用。
Epigenetics. 2025 Dec;20(1):2536786. doi: 10.1080/15592294.2025.2536786. Epub 2025 Jul 23.
3
Association of metabolic dysregulation with treatment response in rectal cancer patients undergoing chemoradiotherapy.接受放化疗的直肠癌患者代谢失调与治疗反应的关联

本文引用的文献

1
The roles and implications of RNA mA modification in cancer.RNA mA 修饰在癌症中的作用和影响。
Nat Rev Clin Oncol. 2023 Aug;20(8):507-526. doi: 10.1038/s41571-023-00774-x. Epub 2023 May 23.
2
GPX8 deficiency-induced oxidative stress reprogrammed m6A epitranscriptome of oral cancer cells.GPX8 缺乏诱导的氧化应激重编程口腔癌细胞的 m6A 转录组。
Epigenetics. 2023 Dec;18(1):2208707. doi: 10.1080/15592294.2023.2208707.
3
Aberrant RNA mA modification in gastrointestinal malignancies: versatile regulators of cancer hallmarks and novel therapeutic opportunities.
BMC Med Genomics. 2025 Mar 12;18(1):48. doi: 10.1186/s12920-025-02114-7.
4
Multidimensional applications of prussian blue-based nanoparticles in cancer immunotherapy.基于普鲁士蓝的纳米颗粒在癌症免疫治疗中的多维应用。
J Nanobiotechnology. 2025 Mar 3;23(1):161. doi: 10.1186/s12951-025-03236-x.
5
FOXM1-activated IGF2BP3 promotes cell malignant phenotypes and M2 macrophage polarization in hepatocellular carcinoma by inhibiting ferroptosis via stabilizing RRM2 mRNA in an m6A-dependent manner.FOXM1激活的IGF2BP3通过以m6A依赖的方式稳定RRM2 mRNA来抑制铁死亡,从而促进肝癌细胞的恶性表型和M2巨噬细胞极化。
Mol Cell Biochem. 2025 May;480(5):3051-3066. doi: 10.1007/s11010-024-05170-2. Epub 2024 Dec 4.
6
Screening of m6A-associated ferroptosis-related genes in atherosclerosis based on WGCNA.基于加权基因共表达网络分析筛选动脉粥样硬化中与m6A相关的铁死亡相关基因
Front Cardiovasc Med. 2024 Oct 28;11:1469805. doi: 10.3389/fcvm.2024.1469805. eCollection 2024.
7
Stress response regulation of mRNA translation: Implications for antioxidant enzyme expression in cancer.mRNA 翻译调控应激反应:对癌症抗氧化酶表达的影响。
Proc Natl Acad Sci U S A. 2024 Nov 12;121(46):e2317846121. doi: 10.1073/pnas.2317846121. Epub 2024 Nov 4.
8
MMP9 drives ferroptosis by regulating GPX4 and iron signaling.基质金属蛋白酶9通过调节谷胱甘肽过氧化物酶4和铁信号传导来驱动铁死亡。
iScience. 2024 Jul 30;27(9):110622. doi: 10.1016/j.isci.2024.110622. eCollection 2024 Sep 20.
胃肠道恶性肿瘤中异常的 RNA mA 修饰:癌症标志的多功能调节剂和新的治疗机会。
Cell Death Dis. 2023 Apr 4;14(4):236. doi: 10.1038/s41419-023-05736-w.
4
m6A writer WTAP targets NRF2 to accelerate bladder cancer malignancy via m6A-dependent ferroptosis regulation.m6A 书写器WTAP通过依赖m6A的铁死亡调节作用靶向NRF2以加速膀胱癌恶性进展。
Apoptosis. 2023 Apr;28(3-4):627-638. doi: 10.1007/s10495-023-01817-5. Epub 2023 Jan 31.
5
WTAP-mediated m6A modification on circCMTM3 inhibits hepatocellular carcinoma ferroptosis by recruiting IGF2BP1 to increase PARK7 stability.WTAP 介导的 circCMTM3 m6A 修饰通过招募 IGF2BP1 增加 PARK7 稳定性来抑制肝细胞癌铁死亡。
Dig Liver Dis. 2023 Jul;55(7):967-981. doi: 10.1016/j.dld.2022.12.005. Epub 2022 Dec 30.
6
Inducing ferroptosis has the potential to overcome therapy resistance in breast cancer.诱导铁死亡有可能克服乳腺癌的治疗抵抗。
Front Immunol. 2022 Nov 24;13:1038225. doi: 10.3389/fimmu.2022.1038225. eCollection 2022.
7
Hyperbaric oxygen enhances X-ray induced ferroptosis in oral squamous cell carcinoma cells.高压氧增强 X 射线诱导的口腔鳞状细胞癌细胞铁死亡。
Oral Dis. 2024 Mar;30(2):116-127. doi: 10.1111/odi.14461. Epub 2022 Dec 28.
8
Fear stress promotes glioma progression through inhibition of ferroptosis by enhancing FSP1 stability.恐惧应激通过增强 FSP1 稳定性抑制铁死亡促进胶质瘤进展。
Clin Transl Oncol. 2023 May;25(5):1378-1388. doi: 10.1007/s12094-022-03032-1. Epub 2022 Dec 9.
9
IGF2BP3 is an essential N-methyladenosine biotarget for suppressing ferroptosis in lung adenocarcinoma cells.IGF2BP3是抑制肺腺癌细胞铁死亡的关键N-甲基腺苷生物靶点。
Mater Today Bio. 2022 Nov 24;17:100503. doi: 10.1016/j.mtbio.2022.100503. eCollection 2022 Dec 15.
10
METTL16 epigenetically enhances GPX4 expression via m6A modification to promote breast cancer progression by inhibiting ferroptosis.METTL16通过m6A修饰在表观遗传上增强GPX4表达,以通过抑制铁死亡促进乳腺癌进展。
Biochem Biophys Res Commun. 2023 Jan 1;638:1-6. doi: 10.1016/j.bbrc.2022.10.065. Epub 2022 Oct 26.